The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population

Journal article

Peer reviewed

Abdullah Alkattan, Yousef Almutairi, Eman Alsalameen, Ahmed Alkhalifah and Fatimah Alghanim

Indian journal of pharmacology, Vol.53(1), pp.85-87

01/2021

PMID: 33976007

Abstract

Arabs

Clopidogrel - therapeutic use

Cytochrome P-450 CYP2C19 - genetics

Genotype

Humans

Middle East

Platelet Aggregation Inhibitors - therapeutic use

Whites - genetics

1 Record Views

Title: The CYP2C19 genotypes and its effect on clopidogrel as an anti-platelet drug among the Arab population
Creators - without role: Abdullah Alkattan - King Faisal University
Yousef Almutairi - Saudi Center for Disease Prevention and Control
Eman Alsalameen - King Khalid University Hospital
Ahmed Alkhalifah - Department of Sales, Fresenius Kabi, Alhaya Medical Company, Dammam, Saudi Arabia.
Fatimah Alghanim - Imam Abdulrahman Bin Faisal University
Publication Details: Indian journal of pharmacology, Vol.53(1), pp.85-87
Identifiers: 9924185408331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article